| Source: |
| Type: |
| LTC4 - Leukotriene C4 Abbreviation: LTC4 Type: Cysteinyl leukotriene / eicosanoid inflammatory lipid mediator Pathway: Arachidonic acid → 5-LOX/FLAP → LTA4 → LTC4 synthase → LTC4 → LTD4 → LTE4 Function: LTC4 is the first cysteinyl leukotriene produced from LTA4 by LTC4 synthase through conjugation with glutathione. After export from cells, LTC4 is sequentially converted to LTD4 and LTE4. Cysteinyl leukotrienes signal primarily through CysLT receptors including CYSLTR1 and CYSLTR2 and regulate airway smooth-muscle contraction, vascular permeability, mucus secretion, eosinophilic inflammation, and tissue remodeling. Asthma: ↑ Increased LTC4 and downstream cysteinyl leukotriene signaling are strongly associated with allergic and eosinophilic asthma. Elevated LTC4 contributes to bronchoconstriction, mucus hypersecretion, airway edema, eosinophilic inflammation, airway hyperresponsiveness, and remodeling. Favorable Direction in Asthma: ↓ LTC4 production or cysteinyl leukotriene signaling is generally favorable and reduces bronchoconstriction and allergic airway inflammation. Cancer: ↕ Context-dependent. LTC4 and downstream cysteinyl leukotrienes can influence proliferation, survival, migration, angiogenesis, inflammation, and tumor-microenvironment signaling. The net effect depends strongly on cancer type and the relative activity of CysLT1 and CysLT2 receptors. |
| 7941- | TQ, | Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma |
| - | in-vivo, | Asthma, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1742 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid